Does needle biopsy encourage breast Ca spread?

Article

Women who receive fine-needle aspiration (FNA) or large-gauge needle core biopsy of breast cancer tissue are about 50% more likely to have sentinel node metastases than women who undergo tumor removal, according to a recent prospective database study from California.

Women who receive fine-needle aspiration (FNA) or large-gauge needle core biopsy of breast cancer tissue are about 50% more likely to have sentinel node metastases than women who undergo tumor removal, according to a recent prospective database study from California.

Researchers included 663 women with a mean age of 58 years and a mean tumor size of 1.85 cm. Women biopsied using FNA were about 53% more likely and those receiving large-gauge needle core biopsy were about 48% more likely to have their cancer spread to lymph nodes than women receiving excision.

Researchers surmise that the increased rate of spread has something to do with mechanical disruption of the tumor. The findings could be significant if one considers that the spread of cancer to the sentinel node decreases a woman's survival and influences the type of treatment she receives.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.